Skip to content
DataLookout
Menu

NCT07896343

Understanding the Neural Underpinnings of Risk-Taking Behavior in Psychiatric Disease

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Difference in Orbitofrontal Cortex High-Frequency Activity (70-150 Hz) Between Approach and Avoidance Decisions
Timeframe: During task session(s) completed during inpatient sEEG monitoring, from enrollment up to 3 weeks

Arms and interventions

Approach-Avoidance Task During sEEG MonitoringExperimental

Adults undergoing inpatient stereo-EEG (sEEG) monitoring with electrodes in the orbitofrontal cortex (OFC). The primary cohort consists of patients with treatment-resistant depression enrolled under the parent IRB protocol of a deep brain stimulation trial for refractory depression (PRESIDIO; NCT04004169), who undergo sEEG with bilateral OFC electrodes during that trial's inpatient phase. The control cohort consists of non-depressed patients undergoing sEEG monitoring for other clinical indications, such as seizure localization in refractory epilepsy. All participants complete the same computerized approach-avoidance decision-making task (\~20 minutes per session), choosing on each trial to approach or avoid offers of probabilistic reward and punishment, while neural activity is recorded from the implanted electrodes. No drug, device, or stimulation is administered as part of this study; implantation and any stimulation occur solely under clinical care or the parent trial.

Behavioral: Approach-Avoidance Decision-Making Task

Sites

1 site in 1 country

  • UCSFSan Francisco, California, United States